Sign up to save your podcasts
Or
Share Potential ASCO Practice-Changers in HER2+ Breast Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Potential ASCO Practice-Changers in HER2+ Breast Cancer
Oncologists will debate the APHINITY trial data for years to come, says Dr Kevin Kalinsky.
View all episodes
By MedscapeOncologists will debate the APHINITY trial data for years to come, says Dr Kevin Kalinsky.